Full Text
Assessing The Impact Of Patient-Reported Outcomes And Health Economic Benefit Claims On The Market Value Of Oncologic Pharmaceuticals

Abstract

Authors

J.D. Miller K.M. Ruiz D.D. Gagnon K.A. Foley H.V. Varker G.M. Lenhart

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×